Background: Stroke is a leading cause of long-term disability in the United States (US). Assisted Cycling Therapy (ACT) incorporates the use of an electric motor to enhance the rotations per minute (rpm). ACT of about 80 rpm, has been associated with improvements in motor, cognitive, and clinical function. The acute effects of ACT on motor and cognitive function of persons with stroke induced deficits have not been investigated.

Purpose: To compare the acute effects of ACT, voluntary cycling (VC), and no cycling (NC) on upper and lower extremity motor function and executive function in adults with chronic stroke (age: 60 ± 16 years; months since stroke: 96 ± 85).

Methods: Twenty-two participants (gender: female = 6, male = 16; types: ischemic = 12, hemorrhagic = 10; sides: left lesion = 15, right lesion = 7) completed one session of ACT, one session of VC and one session of NC on separate days using a 3 x 3 crossover design.

Results: ACT lead to greater improvements in lower and upper extremity function on the paretic and non-paretic side than VC or NC (all p < 0.05), except in the non-paretic lower extremity where ACT and VC produced similar improvement (both p < 0.05). ACT and VC, but not NC, were associated with improvements in inhibition (p < 0.05). A positive relationship between cadence and motor function (P < 0.05) was found. Ratings of perceived exertion shared an inverted-U shaped relationship with measures of processing speed (p < 0.05) and a negative linear relationship with measures of executive function (p < 0.05).

Conclusion: ACT appears to benefit paretic and non-paretic motor function globally whereas the benefits of VC are more task specific. Faster cycling cadence was associated with greater improvements in global motor function. ACT and VC seem to carry similar acute benefits in inhibition.

Background: Postprandial hyperglycemia can increase levels of oxidative stress and is an independent risk factor for complications associated with type 2 diabetes.

Purpose: To evaluate the acute effects of a 15-min postmeal walk on glucose control and markers of oxidative stress following a high-carbohydrate meal.

Methods: Ten obese subjects (55.0 ± 10.0 yrs) with impaired fasting glucose (107.1 ± 9.0 mg/dL) participated in this repeated measures trial. Subjects arrived at the laboratory following an overnight fast and underwent one of three conditions: 1) Test meal with no walking or fiber (CON), 2) Test meal with 10g fiber and no walking (FIB), 3) Test meal with no fiber followed by a 15-min treadmill walk at preferred walking speed (WALK). Blood samples were taken over four hours and assayed for glucose, insulin, thiobarbituric reactive substances (TBARS), catalase, uric acid, and total antioxidant capacity (TAC). A repeated measures ANOVA was used to compare mean differences for all outcome variables.

Results: The 2hr and 4hr incremental area under the curve (iAUC) for glucose was lower in both FIB (2hr: -93.59 mmol∙120 min∙L-1, p = 0.006; 4hr: -92.59 mmol∙240 min∙L-1; p = 0.041) and WALK (2hr: -77.21 mmol∙120 min∙L-1, p = 0.002; 4hr: -102.94 mmol∙240 min∙L-1; p = 0.005) conditions respectively, compared with CON. There were no differences in 2hr or 4hr iAUC for glucose between FIB and WALK (2hr: p = 0.493; 4hr: p = 0.783). The 2hr iAUC for insulin was significantly lower in both FIB (-37.15 μU ∙h/mL; p = 0.021) and WALK (-66.35 μU ∙h/mL; p < 0.001) conditions, compared with CON, and was significantly lower in the WALK (-29.2 μU ∙h/mL; p = 0.049) condition, compared with FIB. The 4hr iAUC for insulin in the WALK condition was significantly lower than both CON (-104.51 μU ∙h/mL; p = 0.001) and FIB (-77.12 μU ∙h/mL; p = 0.006) conditions. Markers of oxidative stress were not significantly different between conditions.

Conclusion: A moderate 15-minute postmeal walk is an effective strategy to reduce postprandial hyperglycemia. However, it is unclear if this attenuation could lead to improvements in postprandial oxidative stress.